Wendy Chang

Human Resources Officer at HARPOON THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Wendy Chang is currently the Chief People Officer at Harpoon Therapeutics, Inc. She previously worked at IDbyDNA, Inc. as the Head of People & Culture.
Ms. Chang completed her undergraduate degree at the University of California.

Wendy Chang active positions

Companies	Position	Start
HARPOON THERAPEUTICS, INC.	Human Resources Officer	06/07/2022

All active positions of Wendy Chang

Former positions of Wendy Chang

Companies	Position	End
IDbyDNA, Inc. IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA.	Human Resources Officer	-

See the detail of Wendy Chang's experience

Training of Wendy Chang

University of California

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wendy Chang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HARPOON THERAPEUTICS, INC.	Health Technology

Private companies	1
IDbyDNA, Inc. IDbyDNA, Inc. BiotechnologyHealth Technology IDbyDNA, Inc. operates as a precision medicine company that focuses on metagenomic approaches for infectious disease identification. It develops technologies to enable universal microorganism detection. The firm help doctors and scientists to detect any pathogen in any sample, thereby removing barriers for the adoption of metagenomics in clinical settings, ultimately leading to faster public health responses during infectious disease outbreaks. The company was founded by Martin G. Reese, Guochun Liao, Mark Yandell, and Robert Schlaberg in Noveber 2014 and is headquartered in San Mateo, CA.	Health Technology